Mazelsky Jonathan Jay's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Sep 5, 2023
- Accession no.
- 0000874716-23-000117
- Filed
- Sep 5, 2023
- Trade date
- Aug 31, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.87M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazelsky Jonathan JayCIK 0001556270 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | Common Stock | MOption exerciseAcquired | +13,424 | $79.54 | +$1,067,744.96 | 86,349.35 | Direct | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −13,424 | $512.01F1 | −$6,873,222.24 | 72,925.35 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | Common Stock | MOption exerciseDisposed | −13,424 | –F3 | – | 13,424 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average price of the shares sold ranging from a low of $512.00 to a high of $512.49 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Not applicable.
Referenced by the price of 1 transaction in Table II.